Coinbase CEO co-founded longevity research company NewLimit, which has recently secured an additional $45 million in funding

ChainCatcher news, Coinbase CEO co-founded longevity research company NewLimit forwarded a message from its co-founder Jacob Kimmel stating that NewLimit has recently secured an additional $45 million in funding, with investors including Lilly Ventures, Duke University, S32, Abstract, and participation from existing shareholders such as Kleiner Perkins, Dimension, Human Capital, and Boost VC.

This round of financing is based on technological breakthroughs in its young liver function restoration project, with plans to initiate clinical research in the coming years.